These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 33364229)

  • 1. Identification of Small Molecule Inhibitors of the Deubiquitinating Activity of the SARS-CoV-2 Papain-Like Protease:
    Pitsillou E; Liang J; Ververis K; Lim KW; Hung A; Karagiannis TC
    Front Chem; 2020; 8():623971. PubMed ID: 33364229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of small molecules with the SARS-CoV-2 papain-like protease: In silico studies and in vitro validation of protease activity inhibition using an enzymatic inhibition assay.
    Pitsillou E; Liang J; Ververis K; Hung A; Karagiannis TC
    J Mol Graph Model; 2021 May; 104():107851. PubMed ID: 33556646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishing an Analogue Based In Silico Pipeline in the Pursuit of Novel Inhibitory Scaffolds against the SARS Coronavirus 2 Papain-Like Protease.
    Hajbabaie R; Harper MT; Rahman T
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33672721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of small molecule inhibitors of the SARS-CoV-2 papain-like protease by all-atom microsecond modelling, PELE Monte Carlo simulations, and
    Liang JJ; Pitsillou E; Ververis K; Guallar V; Hung A; Karagiannis TC
    Chem Phys Lett; 2022 Feb; 788():139294. PubMed ID: 34961797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of small molecules with the SARS-CoV-2 main protease in silico and in vitro validation of potential lead compounds using an enzyme-linked immunosorbent assay.
    Pitsillou E; Liang J; Karagiannis C; Ververis K; Darmawan KK; Ng K; Hung A; Karagiannis TC
    Comput Biol Chem; 2020 Dec; 89():107408. PubMed ID: 33137690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of interferon-stimulated gene 15 and lysine 48-linked ubiquitin binding to the SARS-CoV-2 papain-like protease by small molecules:
    Pitsillou E; Liang J; Hung A; Karagiannis TC
    Chem Phys Lett; 2021 May; 771():138468. PubMed ID: 33716308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization of the EpiMed Coronabank Chemical Collection to identify potential SARS-CoV-2 antivirals: in silico studies targeting the nsp14 ExoN domain and PL
    Liang JJ; Pitsillou E; Lau HLY; Mccubbery CP; Gan H; Hung A; Karagiannis TC
    J Mol Graph Model; 2024 Sep; 131():108803. PubMed ID: 38815531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small molecule interactions with the SARS-CoV-2 main protease: In silico all-atom microsecond MD simulations, PELE Monte Carlo simulations, and determination of in vitro activity inhibition.
    Liang J; Pitsillou E; Ververis K; Guallar V; Hung A; Karagiannis TC
    J Mol Graph Model; 2022 Jan; 110():108050. PubMed ID: 34655918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compounds derived from Humulus lupulus inhibit SARS-CoV-2 papain-like protease and virus replication.
    Herzog AM; Göbel K; Marongiu L; Ruetalo N; Alonso MC; Leischner C; Busch C; Burkard M; Lauer UM; Geurink PP; Knobeloch KP; Schindler M; Fritz G; Venturelli S
    Phytomedicine; 2024 Jan; 123():155176. PubMed ID: 37976697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Phytochemicals from Arabian Peninsula Medicinal Plants as Strong Binders to SARS-CoV-2 Proteases (3CL
    Saquib Q; Bakheit AH; Ahmed S; Ansari SM; Al-Salem AM; Al-Khedhairy AA
    Molecules; 2024 Feb; 29(5):. PubMed ID: 38474509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based design of SARS-CoV-2 papain-like protease inhibitors.
    Jadhav P; Huang B; Osipiuk J; Zhang X; Tan H; Tesar C; Endres M; Jedrzejczak R; Tan B; Deng X; Joachimiak A; Cai J; Wang J
    Eur J Med Chem; 2024 Jan; 264():116011. PubMed ID: 38065031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of SARS-CoV-2 papain-like protease inhibitors through a combination of high-throughput screening and FlipGFP-based reporter assay.
    Xia Z; Sacco MD; Ma C; Townsend JA; Kitamura N; Hu Y; Ba M; Szeto T; Zhang X; Meng X; Zhang F; Xiang Y; Marty MT; Chen Y; Wang J
    bioRxiv; 2021 Mar; ():. PubMed ID: 33758866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-Based Identification of Naphthoquinones and Derivatives as Novel Inhibitors of Main Protease M
    Santos LH; Kronenberger T; Almeida RG; Silva EB; Rocha REO; Oliveira JC; Barreto LV; Skinner D; Fajtová P; Giardini MA; Woodworth B; Bardine C; Lourenço AL; Craik CS; Poso A; Podust LM; McKerrow JH; Siqueira-Neto JL; O'Donoghue AJ; da Silva Júnior EN; Ferreira RS
    J Chem Inf Model; 2022 Dec; 62(24):6553-6573. PubMed ID: 35960688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of potential plant-based inhibitor against viral proteases of SARS-CoV-2 through molecular docking, MM-PBSA binding energy calculations and molecular dynamics simulation.
    Gogoi B; Chowdhury P; Goswami N; Gogoi N; Naiya T; Chetia P; Mahanta S; Chetia D; Tanti B; Borah P; Handique PJ
    Mol Divers; 2021 Aug; 25(3):1963-1977. PubMed ID: 33856591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emerging SARS-CoV-2 papain-like protease: Its relationship with recent coronavirus epidemics.
    Kandeel M; Kitade Y; Fayez M; Venugopala KN; Ibrahim A
    J Med Virol; 2021 Mar; 93(3):1581-1588. PubMed ID: 32902889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug Repurposing for the SARS-CoV-2 Papain-Like Protease.
    Cho CC; Li SG; Lalonde TJ; Yang KS; Yu G; Qiao Y; Xu S; Ray Liu W
    ChemMedChem; 2022 Jan; 17(1):e202100455. PubMed ID: 34423563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass spectrometric assays monitoring the deubiquitinase activity of the SARS-CoV-2 papain-like protease inform on the basis of substrate selectivity and have utility for substrate identification.
    Brewitz L; Henry Chan HT; Lukacik P; Strain-Damerell C; Walsh MA; Duarte F; Schofield CJ
    Bioorg Med Chem; 2023 Nov; 95():117498. PubMed ID: 37857256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Silico Identification of Inhibitory Compounds for SARS-Cov-2 Papain-Like Protease.
    Miwa K; Guo Y; Hata M; Hirano Y; Yamamoto N; Hoshino T
    Chem Pharm Bull (Tokyo); 2023; 71(12):897-905. PubMed ID: 38044142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass Spectrometric Assays Reveal Discrepancies in Inhibition Profiles for the SARS-CoV-2 Papain-Like Protease.
    Brewitz L; Kamps JJAG; Lukacik P; Strain-Damerell C; Zhao Y; Tumber A; Malla TR; Orville AM; Walsh MA; Schofield CJ
    ChemMedChem; 2022 May; 17(9):e202200016. PubMed ID: 35085423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Silico and In Vitro Identification of Pan-Coronaviral Main Protease Inhibitors from a Large Natural Product Library.
    Shahhamzehei N; Abdelfatah S; Efferth T
    Pharmaceuticals (Basel); 2022 Mar; 15(3):. PubMed ID: 35337106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.